vs

Side-by-side financial comparison of CLEANSPARK, INC. (CLSK) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $181.2M, roughly 1.1× CLEANSPARK, INC.). REPLIGEN CORP runs the higher net margin — 6.7% vs -209.0%, a 215.7% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 11.6%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $-198.1M). Over the past eight quarters, CLEANSPARK, INC.'s revenue compounded faster (106.4% CAGR vs 14.4%).

CleanSpark, Inc. is a U.S.-headquartered sustainable technology company operating two core business segments: low-carbon Bitcoin mining powered primarily by renewable and stranded energy resources, and end-to-end microgrid design, deployment, and operation services for commercial, industrial, and public sector clients across North America.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

CLSK vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.1× larger
RGEN
$197.9M
$181.2M
CLSK
Growing faster (revenue YoY)
RGEN
RGEN
+2.0% gap
RGEN
13.6%
11.6%
CLSK
Higher net margin
RGEN
RGEN
215.7% more per $
RGEN
6.7%
-209.0%
CLSK
More free cash flow
RGEN
RGEN
$215.6M more FCF
RGEN
$17.6M
$-198.1M
CLSK
Faster 2-yr revenue CAGR
CLSK
CLSK
Annualised
CLSK
106.4%
14.4%
RGEN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLSK
CLSK
RGEN
RGEN
Revenue
$181.2M
$197.9M
Net Profit
$-378.7M
$13.3M
Gross Margin
47.2%
52.5%
Operating Margin
-174.7%
9.0%
Net Margin
-209.0%
6.7%
Revenue YoY
11.6%
13.6%
Net Profit YoY
-253.5%
143.9%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLSK
CLSK
RGEN
RGEN
Q4 25
$181.2M
$197.9M
Q3 25
$188.8M
Q2 25
$182.4M
Q1 25
$169.2M
Q4 24
$174.1M
Q3 24
$89.3M
$154.9M
Q2 24
$104.1M
$154.1M
Q1 24
$111.8M
$151.3M
Net Profit
CLSK
CLSK
RGEN
RGEN
Q4 25
$-378.7M
$13.3M
Q3 25
$14.9M
Q2 25
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$-62.2M
$-654.0K
Q2 24
$-236.2M
$3.3M
Q1 24
$126.7M
$2.1M
Gross Margin
CLSK
CLSK
RGEN
RGEN
Q4 25
47.2%
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
36.0%
50.0%
Q2 24
56.6%
49.8%
Q1 24
69.3%
49.5%
Operating Margin
CLSK
CLSK
RGEN
RGEN
Q4 25
-174.7%
9.0%
Q3 25
8.9%
Q2 25
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-73.5%
-5.1%
Q2 24
-239.2%
1.0%
Q1 24
1.3%
Net Margin
CLSK
CLSK
RGEN
RGEN
Q4 25
-209.0%
6.7%
Q3 25
7.9%
Q2 25
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
-69.6%
-0.4%
Q2 24
-226.9%
2.2%
Q1 24
113.4%
1.4%
EPS (diluted)
CLSK
CLSK
RGEN
RGEN
Q4 25
$0.24
Q3 25
$0.26
Q2 25
$0.26
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLSK
CLSK
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$458.1M
$767.6M
Total DebtLower is stronger
$1.8B
$542.2M
Stockholders' EquityBook value
$1.4B
$2.1B
Total Assets
$3.3B
$2.9B
Debt / EquityLower = less leverage
1.29×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLSK
CLSK
RGEN
RGEN
Q4 25
$458.1M
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$121.2M
$784.0M
Q2 24
$126.1M
$809.1M
Q1 24
$780.6M
Total Debt
CLSK
CLSK
RGEN
RGEN
Q4 25
$1.8B
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
$7.2M
Q2 24
$1.3M
Q1 24
$5.1M
Stockholders' Equity
CLSK
CLSK
RGEN
RGEN
Q4 25
$1.4B
$2.1B
Q3 25
$2.1B
Q2 25
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$1.8B
$2.0B
Q2 24
$1.4B
$2.0B
Q1 24
$1.5B
$2.0B
Total Assets
CLSK
CLSK
RGEN
RGEN
Q4 25
$3.3B
$2.9B
Q3 25
$2.9B
Q2 25
$2.9B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$2.0B
$2.8B
Q2 24
$1.5B
$2.9B
Q1 24
$1.5B
$2.8B
Debt / Equity
CLSK
CLSK
RGEN
RGEN
Q4 25
1.29×
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLSK
CLSK
RGEN
RGEN
Operating Cash FlowLast quarter
$-161.1M
$25.7M
Free Cash FlowOCF − Capex
$-198.1M
$17.6M
FCF MarginFCF / Revenue
-109.3%
8.9%
Capex IntensityCapex / Revenue
20.4%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$-626.9M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLSK
CLSK
RGEN
RGEN
Q4 25
$-161.1M
$25.7M
Q3 25
$48.1M
Q2 25
$28.6M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$-233.7M
$49.3M
Q2 24
$-58.4M
$42.2M
Q1 24
$-44.8M
$44.7M
Free Cash Flow
CLSK
CLSK
RGEN
RGEN
Q4 25
$-198.1M
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$-299.8M
$42.3M
Q2 24
$-68.7M
$37.4M
Q1 24
$-60.3M
$36.4M
FCF Margin
CLSK
CLSK
RGEN
RGEN
Q4 25
-109.3%
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
-335.8%
27.3%
Q2 24
-66.0%
24.3%
Q1 24
-54.0%
24.0%
Capex Intensity
CLSK
CLSK
RGEN
RGEN
Q4 25
20.4%
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
74.0%
4.5%
Q2 24
9.9%
3.1%
Q1 24
13.8%
5.5%
Cash Conversion
CLSK
CLSK
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
-0.35×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons